Escherichia coli, commonly known as E. coli, are bacteria that live in the intestines of humans and animals. E. coli strains are used in the production of commercial products such as vaccines, antibodies, antibiotics, probiotics and diagnostics. The demand for E. coli strains is growing due to their widespread application in food safety and quality testing in food & beverage industries. Foodborne diseases remain a major public health problem worldwide and are linked to contaminated food and water sources. Testing food and water samples for harmful bacteria like E. coli has become necessary to ensure food safety.
The global Escherichia Coli Strain Market is estimated to be valued at US$ 1.97 Bn in 2023 and is expected to exhibit a CAGR of 24.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The demand for E. coli strains is being propelled by growing focus on food safety and quality testing in food & beverage industries. Regulatory agencies across countries have made it mandatory to test food and water samples for presence of pathogenic bacteria to curb foodborne illnesses. Establishments in food processing and production industries extensively use E. coli strains to detect contamination in raw materials, ingredients and finished food products. This helps identify sources of contamination and take corrective actions to maintain food safety standards. The growing role of E. coli strains in ensuring food safety compliance as per regulatory protocols is expected to drive its demand over the forecast period.
SWOT Analysis
Strength: The Escherichia Coli Strain Market Demand has strong from biotechnology companies to develop novel therapeutics. Certain strains of E. coli are robust workhorses for recombinant protein expression which drives research.
Weakness: Pathogenic strains of E. coli can cause illness in humans and regulatory requirements for handling can increase costs. Traditional antibiotic treatments limit some opportunities.
Opportunity: Advancements in genome editing technologies allow for faster development of engineered E. coli with novel capabilities. Synthetic biology applications for sustainable manufacturing offer growth prospects.
Threats: Natural disasters or emergencies may disrupt supply chains. Potential misuse of engineered bacteria could increase regulatory scrutiny.
Key Takeaways
The global Escherichia Coli strain market is expected to witness high growth over the forecast period driven by expanding research in synthetic biology, recombinant therapeutics and industrial biotechnology. North America currently dominates the market supported by significant R&D investments from governments and private organizations in the region. Manufacturers are exploring applications of engineered E. coli for production of biofuels, biochemicals, enzymes and materials.
Key players operating in the Escherichia Coli strain market are Veritas Technologies Llc., Actifio Inc., Veeam Softwares, Commvault Systems Inc., Symantec Corporation, Ca Technologies, Microsoft Corporation, Dell Technologies Inc., Ibm Corporation, and Hewlett Packard Enterprise. The market is competitive with these players focusing on new product launches and investments to strengthen their portfolios. Partnerships between industry and academia also aim to accelerate applications of E. coli biology.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.